Chemoprevention Indication Score: A user-friendly tool for prevention of breast cancer – Pilot analysis
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference33 articles.
1. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study;Fisher;J Natl Cancer Inst,1998
2. Overview of the main outcomes in breast cancer prevention trials;Cuzick;Lancet,2003
3. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene;Chlebowski;J Clin Oncol,1999
4. Chemoprevention of breast cancer: recommendations and rationale;US Preventive Task Force;Ann Intern Med,2002
5. ACOG committee opinion. Tamoxifen and the prevention of breast cancer in high risk women. Number 224, October 1999;Int J Gynecol Obstet,2000
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Endocrine prevention of breast cancer;Molecular and Cellular Endocrinology;2021-06
2. Risk-reducing medications for primary breast cancer: a network meta-analysis;Cochrane Database of Systematic Reviews;2019-04-29
3. Risk-reducing medication for primary breast cancer: a network meta-analysis;Cochrane Database of Systematic Reviews;2016-05-13
4. Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis;Annals of Oncology;2016-04
5. Barriers to the Use of Breast Cancer Risk Reduction Therapies;Journal of the National Comprehensive Cancer Network;2015-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3